Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $29.4 Million - $39 Million
250,000 New
250,000 $34.5 Million
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $7.73 Million - $9.94 Million
100,000 Added 50.0%
300,000 $2.91 Million
Q3 2021

Nov 15, 2021

SELL
$65.97 - $92.48 $3.3 Million - $4.62 Million
-50,000 Reduced 20.0%
200,000 $2.19 Million
Q2 2019

Aug 14, 2019

BUY
$112.21 - $151.95 $28.1 Million - $38 Million
250,000 New
250,000 $5.46 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.71B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.